NewcelX Ltd.

About NewcelX Ltd.

NewcelX is an innovative biopharmaceutical company focused on transforming the future of type 1 diabetes and medicine through next-generation cell therapies. Utilizing platform technologies for regenerative cell therapies and novel active pharmaceutical ingredients (API), the company aims to treat type 1 diabetes, ALS, MS, and other CNS disorders. Founded in 2025 through the merger of Kadimastem Ltd. and NLS Pharmaceutics Ltd., NewcelX is dedicated to delivering functional cures and durable, accessible treatments for significant unmet medical needs.

Products & Services

IsletRx:A stem cell-derived islet therapy designed to restore insulin production in individuals with insulin-dependent diabetes, specifically targeting Type 1 Diabetes.

AstroRx(r):A validated asset focused on treating amyotrophic lateral sclerosis (ALS) through regenerative cell therapy.

DOXA Platform:A novel small-molecule CNS program aimed at addressing various central nervous system disorders.

Holistic Solutions:Comprehensive treatment approaches for various indications using advanced cell therapy technologies.

IsletRx

AstroRx®

DOXA

Specialties

Regenerative Cell Therapies Type 1 Diabetes Treatment Central Nervous System Disorders Human Pluripotent Stem Cell (hPSC) Technology Allogeneic Cell Therapies regenerative cell therapies hPSC technology platform type 1 diabetes treatments ALS and CNS disorder therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 1400000 MR: - FA: $1.4M FAN: 1400000	D: 2026-07-31 FD: 2026-07-31	2 investors
2	RT: Equity Financing T: - FT: Equity Financing	A: 1350000 MR: - FA: $1.35 million FAN: 1350000	D: 2026-04-01 FD: 2026-04-01	1 investors

Private Placement Latest

2026-07-31

$1.4M

2 investors (Pro only)

Equity Financing 2026-04-01

$1.4M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

NewcelX Ltd. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised